Go to deals
Consumer & Retail | Healthcare

Kneipp Group has acquired Pierre Cattier

Kneipp France, a wholly owned subsidiary of the Kneipp Group in Würzburg, Germany, has acquired the French natural cosmetics manufacturer Pierre Cattier. Financial terms of this transaction have not been disclosed.

The Kneipp brand is synonymous with effective, innovative and natural product concepts for health and well-being based on the holistic teachings of Sebastian Kneipp. The Kneipp Group operates worldwide and is a wholly owned subsidiary of Paul Hartmann AG, Heidenheim. The company is looking to further strengthen its position in Germany and internationally by means of acquisitions.

Dietmar Salein, Managing Director of the Kneipp Group, and Daniel Aressy, the owner of Pierre Cattier, signed the purchase agreement for the acquisition of all shares of Pierre Cattier. Kneipp France and Pierre Cattier have merged into one company and will continue to operate under the name Pierre Cattier in France. The new company will be led by Cattier’s Managing Director Alexis Fort and will market both product lines.

Pierre Cattier has been producing and marketing certified natural cosmetics since 1968. Cattier products are organic cosmetics with no parabens, synthetic dyes or fragrances, and no paraffin oil.

Oaklins' team in Germany advised the Kneipp Group on the acquisition process by initiating the transaction and running a structured international search in Germany, Austria, Switzerland and France with the support of Oaklins' teams in Switzerland and France. After having identified a French transaction target, our German and France teams jointly concluded the process from originating the contact with the seller, reviewing the documentation, coordinating the due diligence and advising on the negotiations through to the successful closing of the transaction.

Parties

Talk to the deal team

Dr. Florian von Alten

Managing Partner
Hamburg, Germany
Oaklins Germany

Thibaut de Monclin

Managing Partner
Paris, France
Oaklins France

Related deals

Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
Healthcare

Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland

LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.

Learn more
Armira has signed an agreement to acquire a majority stake in Viabus
Private Equity | Consumer & Retail

Armira has signed an agreement to acquire a majority stake in Viabus

Armira, a Germany-based investment firm, has signed an agreement to acquire a majority stake in Viabus, a leading Dutch tour operator focused on senior and young senior travelers.

Learn more
EuroHospital Varna has been acquired by Intermedica Group
Healthcare

EuroHospital Varna has been acquired by Intermedica Group

EuroHospital Varna has been acquired by Intermedica Group, allowing the business to continue to grow and deliver high-quality healthcare services to its patients. Through the transaction, Intermedica Group expands its healthcare presence and intends to build a new model of integrated personalized care focused on preventive, holistic and digital medicine.

Learn more